StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)

Close on Nov 18, 2026Market cap $1.41BP/E –Yield –

uniQure r&d expenses

Research and development expenses are spending on new products and technology.

uniQure's R&D Expenses for the twelve months ending Jun 30, 2026 was $132.29M, down 6.1% year over year. For fiscal 2025 it was $140.67M, down 2.2% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $214.86M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$140.67M-2.2%
FY2024Dec 31, 2024$143.78M-33.1%
FY2023Dec 31, 2023$214.86M+8.7%
FY2022Dec 31, 2022$197.59M+37.6%
FY2021Dec 31, 2021$143.55M+17.3%
FY2020Dec 31, 2020$122.40M+29.2%
FY2019Dec 31, 2019$94.74M+26.6%
FY2018Dec 31, 2018$74.81M+3.7%
FY2017Dec 31, 2017$72.17M-0.5%
FY2016Dec 31, 2016$72.51M+22.6%
FY2015Dec 31, 2015$59.13M+35.1%
FY2014Dec 31, 2014$43.77M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$33.96M-4.0%
Q1 FY2026Mar 31, 2026$29.18M-19.3%
Q4 FY2025Dec 31, 2025$34.78M-10.4%
Q3 FY2025Sep 30, 2025$34.37M+12.3%
Q2 FY2025Jun 30, 2025$35.38M+5.1%
Q1 FY2025Mar 31, 2025$36.14M-11.2%
Q4 FY2024Dec 31, 2024$38.84M-8.9%
Q3 FY2024Sep 30, 2024$30.60M-53.2%
Q2 FY2024Jun 30, 2024$33.66M-26.9%
Q1 FY2024Mar 31, 2024$40.69M-33.1%
Q4 FY2023Dec 31, 2023$42.62M-26.9%
Q3 FY2023Sep 30, 2023$65.40M+36.1%
Q2 FY2023Jun 30, 2023$46.04M-0.3%
Q1 FY2023Mar 31, 2023$60.81M+35.1%
Q4 FY2022Dec 31, 2022$58.33M+37.8%
Q3 FY2022Sep 30, 2022$48.07M+31.9%
Q2 FY2022Jun 30, 2022$46.19M+41.1%
Q1 FY2022Mar 31, 2022$45.00M+37.8%
Q4 FY2021Dec 31, 2021$42.34M+33.6%
Q3 FY2021Sep 30, 2021$36.43M+0.4%
Q2 FY2021Jun 30, 2021$32.75M+15.3%
Q1 FY2021Mar 31, 2021$32.66M+25.5%
Q4 FY2020Dec 31, 2020$31.68M+19.6%
Q3 FY2020Sep 30, 2020$36.30M+54.1%
Q2 FY2020Jun 30, 2020$28.40M+17.6%
Q1 FY2020Mar 31, 2020$26.01M+26.7%
Q4 FY2019Dec 31, 2019$26.49M+41.5%
Q3 FY2019Sep 30, 2019$23.55M+14.7%
Q2 FY2019Jun 30, 2019$24.15M+30.6%
Q1 FY2019Mar 31, 2019$20.54M+20.4%
Q4 FY2018Dec 31, 2018$18.72M+2.8%
Q3 FY2018Sep 30, 2018$20.54M+2.2%
Q2 FY2018Jun 30, 2018$18.49M+9.6%
Q1 FY2018Mar 31, 2018$17.06M+0.4%
Q4 FY2017Dec 31, 2017$18.21M-8.9%
Q3 FY2017Sep 30, 2017$20.10M+21.1%
Q2 FY2017Jun 30, 2017$16.87M–
Q1 FY2017Mar 31, 2017$16.99M–
Q4 FY2016Dec 31, 2016$19.98M–
Q3 FY2016Sep 30, 2016$16.60M–

More uniQure figures

See a number that looks wrong?